FDA, Danco Oppose States’ Intervention In Abortion Drug Case In High Court

( February 7, 2024, 4:09 PM EST) -- WASHINGTON, D.C. — Three anti-abortion states on Feb. 6 replied to oppositions filed by the U.S. Food and Drug Administration and by Danco Laboratories LLC, the manufacturer of Mifeprex-brand mifepristone, on the states’ motion to intervene in a U.S. Supreme Court case involving the abortion drug with the FDA arguing “that the states waited far too long to seek intervention.”...

Attached Documents

Related Sections